ArticleBMC cancer2025

Comparison analysis of ICIs and chemotherapy combined with or without lenvatinib as first-line treatment of unresectable intrahepatic cholangiocarcinoma.

Miao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.